ALA can enhance the apoptotic potential of cancer cells by increasing the concentration of intracellular reactive oxygen species (ROS), (as seen in DCFDA tests), inducing increased cell apoptosis through the loss of mitochondrial membrane potential, activation of caspase 3 and 9, and by increasing the Bax/Bcl2 ratio [3]. The gene discussed is BCL2; the disease is cancer.